Resveratrol derived from rhizoma et radix polygoni cuspidati and its liposomal form protect nigral cells of parkinsonian rats

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 8, 2011, Pages 1060-1066

  Wang, Yanchun ^a,b   Xu, Hanlin ^b   Fu, Qin ^a   Ma, Rong ^a   Xiang, Jizhou ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Liposome; Oxidative stress; Parkinson's disease; Resveratrol; Rhizoma et radix polygoni cuspidati

Indexed keywords

ANTIOXIDANT; LIPOSOME; NEUROPROTECTIVE AGENT; OXIDOPAMINE; PLANT EXTRACT; POLYGONUM CUSPIDATUM EXTRACT; REACTIVE OXYGEN METABOLITE; RESVERATROL; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BEHAVIOR; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; IMMUNOSUPPRESSIVE TREATMENT; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; POLYGONUM CUSPIDATUM; RAT; RHIZOME;

ANIMALS; ANTIOXIDANTS; BEHAVIOR; CELL DEATH; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; LIPOSOMES; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STILBENES; SUBSTANTIA NIGRA;

EID: 79960342843     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20110826     Document Type: Article

References (25)

1. Abou-Sleiman P M, Muqit M M, Wood N W. Expanding insights of mitochondrial dysfunction in Parkinson's disease[J]. Nat Rev Neurosci, 2006,7(3):207.
2. Hald A, Lotharius J . Oxidative stress and inflammation in Parkinson's disease: is there a causal link [J]. Exp Neurol, 2005,193(2):279.
3. Jang M, Cai L, Udeani G O, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes [J]. Science, 1997,275(5297):218.
4. Soleas G J, Diamandis E P, Goldberg D M. Resveratrol: A molecule whose time has come? And gone? [J]. Clin Biochem, 1997,30(2):91.
5. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances[J]. Mutat Res, 1999,428(1/2):305.
6. Bastianetto S, Zheng W H, Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons[J]. Br J Pharmacol, 2000,131(4):711.
7. Virgili M, Contestabile A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats [J]. Neurosci Lett, 2000,281(2/3):123.
8. Nicolini G, Rigolio R, Miloso M, et al. Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line[J]. Neurosci Lett, 2001,302(1):41.
9. Lee M K, Kang S J, Poncz M, et al. Resveratrol protects SH-SY5Y neuroblastoma ceUs from apoptosis induced by dopamine [J]. Exp Mol Med, 2007,39(3):376.
10. Walle T, Hsieh F, DeLegge M H, et al. High absorption but very low bioavailability of oral resveratrol in humans [J]. Drug Metab Dispos, 2004,32(12):1377.
11. Bemheimer H, Birkmayer W, Homykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations [J]. J Neurol Sci, 1973,20(4):415.
12. Lee D W, Andersen J K. Iron elevations in the aging Parkinsonian brain : A consequence of impaired iron homeostasis [J]. J Neurochem, 2010,112(2):332.
13. Pirkevi C, Lesage S, Brice A, et al. From genes to proteins in mendelian Parkinson's disease: an overview [J]. Anat Rec (Hoboken), 2009,292(12):1893.
14. Olanow C W. A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease[J]. Mov Disord, 1993,8(Suppll):S1.
15. Offen D, Ziv I, Panel H, et al. Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2[J]. Cell Mol Neurobiol, 1997,17(3):289.
16. Hastings T G. Enzymatic oxidation of dopamine : the role of prostaglandin H synthase[J]. J Neurochem, 1995,64(2):919.
17. Jellinger K, Kienzl E, Rumpelmair G, et al. Neuromelanin and nigrostriatal dopamine neuron degeneration [J]. J Neurochem, 1993,60(5):1976.
18. HaUiwell B. Reactive oxygen species and the central nervous system[J]. J Neurochem 1992,59(5):1609.
19. Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha-synuclein[J]. Nat Rev Neurosci, 2002,3(12):932.
20. Karlsson J, Emgard M, Brundin P, et al. Trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: Electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism [J]. J Neurochem, 2000,75(1):141.
21. Sinha K, Chaudhary G, Gupta Y K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats[J]. Life Sci, 2002,71(6):655.
22. Rotondo S, Rajtar G, Manarini S, et al. Effect of transresveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function[J]. Bri J Pharmacol, 1998,123(8):1691.
23. Frankel E N, Waterhouse A L, Kinsella J E. Inhibition of human LDL oxidation by resveratrol [J]. Lancet, 1993,341(8852):1103.